ERIS LIFESCIENCES LTD.

NSE : ERISBSE : 540596ISIN CODE : INE406M01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE881.5011.05 (+1.27 %)
PREV CLOSE ( ) 870.45
OPEN PRICE ( ) 865.75
BID PRICE (QTY) 881.55 (17)
OFFER PRICE (QTY) 883.00 (10)
VOLUME 1455
TODAY'S LOW / HIGH ( )862.00 883.60
52 WK LOW / HIGH ( )603.95 971
NSE879.759.65 (+1.11 %)
PREV CLOSE( ) 870.10
OPEN PRICE ( ) 866.55
BID PRICE (QTY) 880.05 (2)
OFFER PRICE (QTY) 881.25 (8)
VOLUME 13977
TODAY'S LOW / HIGH( ) 860.05 886.45
52 WK LOW / HIGH ( )603.5 971.9
Peer Companies Price () Chg () Chg (%) EPS () TTM P/E Volume (000's) 1 Year Return (%)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.